
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 912587-25-8 | 货号 | BCP36620 |
中文名 | Opigolix | ||
英文名 | Opigolix | ||
中文别名 | |||
英文别名 | ASP1707; ASP-1707; ASP 1707; | ||
SMILES | CC(C(=NS(=O)(=O)C1=C(C=CC(=C1)C(=C(C2=NC3=CC=CC=C3N2)C(=O)C4=C(C=CC(=C4)F)F)O)F)N)O | ||
化学名称 | |||
分子式 | C25H19F3N4O5S | 分子量 | 544.5 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Opigolix, also known as ASP1707, is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which was under development by Astellas Pharma for the treatment of endometriosis and rheumatoid arthritis. It was also under investigation for the treatment of prostate cancer. It reached phase II clinical trials for both endometriosis and rheumatoid arthritis prior to the discontinuation of its development in April 2018. |
Tags:Opigolix 供应商,Opigolix 购买,Opigolix 生产,Opigolix 批量,Opigolix 供应,Opigolix 订购,Opigolix 采购